Same Day Dosing of Pegfilgrastim in Breast Cancer Patients Undergoing Chemotherapy (TAC)
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to provide data on the safety and efficacy of pegfilgrastim when
administered on the same day versus the next day of chemotherapy, as measured by the duration
of grade 4 neutropenia.